Healthvista India, the leading out-of-hospital healthcare provider that operates out-of-hospital healthcare services brand, Portea, said it had filed its Draft Red Herring Prospectus (DRHP) with market regulator Securities and Exchange Board of India (SEBI) for an initial public offering (IPO) to raise up to Rs 1000 crore.
The company plans to raise funds comprising fresh issues aggregating up to Rs 200 crore and an offer for sale of up to 56,252,644 shares.
The company proposes to utilize the net proceeds from the fresh issue towards funding the working capital requirements of material subsidiary Medybiz Pharma, repayment of loans, purchase of medical equipment, marketing and brand building and inorganic growth initiatives and general corporate purposes.
The offer for sale comprises equity shares up to 12,070,214 equity shares by Growth III Holdings (Mauritius) Limited; up to 8,504,709 equity shares by Accel India III (Mauritius) Limited, up to 4,278,680 equity shares by Ventureast Life Fund III LLC Limited; up to 4,445,735 equity shares by MEMG CDC Ventures; up to 4,256,924 equity shares by Qualcomm Asia Pacific Pte Ltd, up to 4,229,951 equity shares by Accel India V (Mauritius) Limited and up to 3,984,752 equity shares by Sabre Partners Trust.
Capital Markets Limited, and are the Book Running Lead Managers.
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.
Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.
